Thats the reason I've sold: a dying volume. In the absence of news I see it bleed off again.

Oh you are quite right, it sounds really great that the patients and their caretakers are already asking to extend the b phase of the study. It means that those taking the medication actually know that it works!

You are quite right, and for those readers not fully in the loop: the combination trial with Merck's anti-pd1 is now actively enrolling. It is an open trial so expect news and data along the way.

As a sidenote, Keytruda has now been approved in the EU for 1st line treatment in advanced melanoma

Seriously, do a reality check! You are setting yourself up for dissappointment.
Take it one step at a time.

To correct you: the patient asking for more of the 'wonder drug' do have AD, so that doesn't qualify them as healthy, although we could have a whole debate on that..

Seems they are succesfull, some here are shitting their pants on otc volatility

Annual shareholders meeting to be webcasted on July 31th 9am PT

http://ir.oncosec.com/press-releases/detail/1834

No it is not. The new CFO is better qualified so we have our selves an upgrade.

Don't we all want trials that are finished in 24 hours. Let me know next time you find one of these.

Trial design is open, so interim data will be available earlier

Ofcourse:

http://finance.yahoo.com/news/european-commission-approves-merck-anti-110000629.html

as always interesting Tom.
Thanks for sharing your insights!

yesterday would have been the day to add!

Also, Keytruda got approved in the EU today for advanced melanoma, both as first-line treatment and for previously treated.

Rejoice, the combination trial is listed on clininicaltrials.gov and is open for enrollment!

You are right Jeff!

The combination trial with Mercks Keytruda is finally registered on clinicaltrials.gov and open for enrollment.

Now the waiting game begins for data. Luckily it is open label so we might hear something sooner rather than later!

To be honest, I don't really care as the new guy seems better qualified and experienced as the old gal. So it's an improvement for the company :)

Hardly worth sweating about

Keep in mind that 6 really is only .30
So much room left to run

thank you for taking the time and educating us, I find this very interesting.
Please keep it up!

AVXL is holding a lot of promise, especially sine their approach to Alzheimers actually seems to work compared to Biogen, Eli Lilly, Axon,... But it still such an unknown company. Hopefully that will change!

keep your feet on the ground maskone, you only set yourself up for disillusions.
One step at a time.

Had an order in at .45 oh well maybe some other day ;)

In any case BIIB was not so great, neither is AXON, and ours is. So we know who will be longterm winners

So what do you make of his claim that 12 patients is hardly data? He has a point kinda because 83% from a 250 patient trial would be perceived a lot more impressive

And our drug actually works!

I'm glad i've kept my shares

But, doesnt mean that their could still be a sell-off due OTC manipulations

Great, it means they know that what they are testing actually works on them!

12 patients data

10 out of 12 show positive cognitive effects at day 36

Competition

http://www.fiercebiotech.com/story/setback-biogens-mid-range-dose-aducanumab-flops-alzheimers-study/2015-07-22

I share your hope

latest tweet reads: We are so happy to be part of #AAIC2015....

Why be happy when you would announce negative results?!

Alzheimer's drug results to be revealed

I got excited by the title, thinking we were trending on BBC News. Alas, other company. Maybe different news tonight :)

We can all use heeps of luck :)

It is a bit weird for a company to favorite tweets about competitors. Most wouldn't do that on social media.

I stand corrected, they are there as favorites. My mistake!

On a sidenote: i do not need God nor his blessing. Can you leave religion out please?

For transparency reasons: got in at .23 and out at .36
Will look to re-enter at a lower range.

Do agree that it could still be a while for human trials to start. I could not find a good reason for the sudden spike in volume and share price, hence took the profit.

I'm sorry to say Wolf but Anavex has not retweeted those tweets. This is their latest:

We are so happy to be a part of #AAIC2015 @alzassociation in Washington DC #EndAlz , our presentation is tomorrow

The previous one dates July 2nd:

Christopher Missling '00, CEO of Anavex named among 3 company leaders leading breakthroughs in tech: kell.gg/1ItifW9 @Anavex_News

For all those following this board: there is zero evidence that the old CFO has been pushed out. Oncosec has communicated she left voluntarily in search of other opportunities. How you interpret it, is up to you. But stating as a fact she has been pushed out is just plane wrong.

OTC has no after hours trade?

Shall we leave religion out as per ihub rules please?